Connected profiles2
Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
PCOS peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label PCOS. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
Registry records
3 selected records.
Connected peptides
2 profiles.
Registry update years
2013–2023 in selected records.
Indication intelligence
Selected evidence landscape
Trial phases1
Phase labels copied from the retained ClinicalTrials.gov versions.
Phase 4 (3)
Registry statuses1
Overall statuses at each retained observation, not necessarily current today.
Completed (3)
Across the connected peptide profiles, PeptideScanner also carries 148 selected PubMed records and 18 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern PCOS unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
Record added
ClinicalTrials.gov record NCT01899430
PeptideScanner retained ClinicalTrials.gov record NCT01899430 at 2026-07-30T21:55:56.626Z. Its registry update date was 2013-07-15, and PeptideScanner's reviewed identity mapping was liraglutide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- July 15, 2013
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT01911468
PeptideScanner retained ClinicalTrials.gov record NCT01911468 at 2026-07-30T21:55:56.619Z. Its registry update date was 2013-07-30, and PeptideScanner's reviewed identity mapping was liraglutide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- July 30, 2013
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT04263415
PeptideScanner retained ClinicalTrials.gov record NCT04263415 at 2026-07-30T19:08:50.175Z. Its registry update date was 2023-09-08, and PeptideScanner's reviewed identity mapping was semaglutide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- September 8, 2023
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Semaglutide · 2023-09-08
ClinicalTrials.gov record NCT04263415
Completed at the retained observation.
Open attributed record →Liraglutide · 2013-07-30
ClinicalTrials.gov record NCT01911468
Completed at the retained observation.
Open attributed record →Liraglutide · 2013-07-15
ClinicalTrials.gov record NCT01899430
Completed at the retained observation.
Open attributed record →